The spread of antibiotic-resistant Staphylococcus aureus urgently demands the development of novel antibiotics. Structure-activity relationship studies of the human kinase inhibitor sorafenib led to the discovery of a new potent antibiotic compound, PK150. The therapeutic potential of PK150 was studied by in vitro and in vivo experiments, revealing a promising pharmacological profile. Additionally, target identification by chemical proteomics and further studies regarding the antibiotic mode of action were conducted.
«
The spread of antibiotic-resistant Staphylococcus aureus urgently demands the development of novel antibiotics. Structure-activity relationship studies of the human kinase inhibitor sorafenib led to the discovery of a new potent antibiotic compound, PK150. The therapeutic potential of PK150 was studied by in vitro and in vivo experiments, revealing a promising pharmacological profile. Additionally, target identification by chemical proteomics and further studies regarding the antibiotic mode of...
»